Dublin, April 04, 2022 (GLOBE NEWSWIRE) -- The "Omega 3 Market Share, Size, Trends, Industry Analysis Report, By Application; By Type; By Source; By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
The global omega 3 market size is expected to reach USD 4.86 billion by 2028 according to this new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
The consumption of omega-3 has increased owing to the increasing disposable income of consumers and rising health-conscious consumers. Growing application in the animal feed and pharmaceutical sectors has boosted the market growth. The outbreak of COVID-19 has increased the demand for the dietary supplements to enhance immunity and improve cardiovascular and mental health during the pandemic. The different types of the product include DHA (Docosahexaenoic Acid), ALA (Alpha-linolenic Acid), and EPA (Eicosapentaenoic Acid).
The demand for DHA and EPA is high owing to their health benefits such as brain development and function, improved cardiovascular health, and mood regulation. The increasing inclination of consumers towards preventive healthcare has fueled the growth of this segment. There has been increased awareness among consumers regarding wellbeing, weight loss, and nutritional requirement of the body, which supplements the development of this segment.
They also support healthy skin and reduce asthma symptoms and allergy risk. Companies operating in this segment are developing healthy food and beverages for specific demographics such as children and the aging population. Introduction of new food products containing omega-3 focuses on providing nutritional benefits and good taste to cater to customer requirements. North America has emerged as the largest market in 2020 and is expected to maintain its dominance over the forecast period. However, the demand from Asia-Pacific is expected to increase during the forecast period. Consumers are increasingly realizing the importance of healthy eating and switching to omega-3 based food & beverages.
Increasing population, growing disposable income, and a greater focus on health and wellness have supported the demand growth. Increasing consciousness towards preventive healthcare during the pandemic and demand for dietary supplements to boost immunity has increased its demand. Market leaders are introducing innovative products to cater to the rising needs of consumers in the region.
Some major industry participants include BASF SE, Cargill, Inc, Lonza Group AG, Epax Norway AS, Koninklijke DSM N.V., Aker Biomarine Antarctic AS, BioProcess Algae, LLC, Croda International Plc, Omega Protein Corporation, GC Reiber Oils, Orkla Health, and FMC Corporation.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Omega 3 Market Insights
4.1. Omega 3 - Industry Snapshot
4.2. Omega 3 Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Omega 3 Market Industry trends
4.6. COVID-19 Impact Analysis
5. Global Omega 3 Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Omega 3 Market, by Type, 2016 - 2028 (USD Billion)
5.3. DHA (Docosahexaenoic Acid)
5.3.1. Global Omega 3 Market, by DHA (Docosahexaenoic Acid), By Region, 2016 - 2028 (USD Billion)
5.4. ALA (Alpha-linolenic Acid)
5.4.1. Global Omega 3 Market, by ALA (Alpha-linolenic Acid), By Region, 2016 - 2028 (USD Billion)
5.5. EPA (Eicosapentaenoic Acid)
5.5.1. Global Omega 3 Market, by EPA (Eicosapentaenoic Acid), by Region, 2016 - 2028 (USD Billion)
6. Global Omega 3 Market, by Source
6.1. Key Findings
6.2. Introduction
6.2.1. Global Omega 3 Market, by Source, 2016 - 2028 (USD Billion)
6.3. Plant-based
6.3.1. Global Omega 3 Market, by Plant-based, by Region, 2016 - 2028 (USD Billion)
6.4. Marine-based
6.4.1. Global Omega 3 Market, by Marine-based, by Region, 2016 - 2028 (USD Billion)
7. Global Omega 3 Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. Global Omega 3 Market, by Application, 2016 - 2028 (USD Billion)
7.3. Pharmaceutical
7.3.1. Global Omega 3 Market, by Pharmaceutical, by Region, 2016 - 2028 (USD Billion)
7.4. Dietary Supplements
7.4.1. Global Omega 3 Market, by Dietary Supplements, by Region, 2016 - 2028 (USD Billion)
7.5. Animal Feed
7.5.1. Global Omega 3 Market, by Animal Feed, by Region, 2016 - 2028 (USD Billion)
7.6. Food & Beverages
7.6.1. Global Omega 3 Market, by Food & Beverages, by Region, 2016 - 2028 (USD Billion)
7.7. Others
7.7.1. Global Omega 3 Market, by Others, by Region, 2016 - 2028 (USD Billion)
8. Omega 3 Market, by Geography
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Aker Biomarine Antarctic AS
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Axellus
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. BASF SE
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. BioProcess Algae, LLC
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Cargill, Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Croda International Plc
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. EPAX
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. FMC Corporation
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. GC Reiber Oils
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Koninklijke DSM N.V.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Lonza
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Luhua Biomarine (Shandong) Co., Ltd.
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Martek Biosciences
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. Nordic Naturals
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. OLVEA Fish Oils
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
10.16. Omega Protein Corporation
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Recent Development
10.17. Pharma Marine AS
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Recent Development
10.18. Pronova
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. Product Benchmarking
10.18.4. Recent Development
10.19. Qualitas Health
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. Product Benchmarking
10.19.4. Recent Development
10.20. Source-omega
10.20.1. Company Overview
10.20.2. Financial Performance
10.20.3. Product Benchmarking
10.20.4. Recent Development
10.21. Simris Alg
10.21.1. Company Overview
10.21.2. Financial Performance
10.21.3. Product Benchmarking
10.21.4. Recent Development
For more information about this report visit https://www.researchandmarkets.com/r/p1pyqf
Attachment
